Sleep disorders in the elderly

Sleep Medicine

Volumn 2, Issue 2, 2001, Pages 99-114

  Phillips, Barbara ^a   Ancoli Israel, Sonia ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apnea; Geriatrics; Hypnotics; Insomnia; Restless legs syndrome; Sleep disordered breathing

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ALPRAZOLAM; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; CAFFEINE; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; CLORAZEPATE; DIAZEPAM; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MELATONIN; NARCOTIC AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; ZALEPLON; ZOLPIDEM;

AGED; AGING; AMNESIA; ANTICHOLINERGIC EFFECT; BEHAVIOR THERAPY; CARDIOTOXICITY; COGNITIVE DEFECT; COGNITIVE THERAPY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG WITHDRAWAL; ELDERLY CARE; EXERCISE; FAMILY HISTORY; FEMALE; HEALTH PRACTITIONER; HUMAN; INSOMNIA; LASER SURGERY; LEISURE; LIGHT EXPOSURE; MALE; OBESITY; ORTHOSTATIC HYPOTENSION; PALATOPLASTY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTMARKETING SURVEILLANCE; PRIAPISM; PRIORITY JOURNAL; RACE; RADIOFREQUENCY; RESPIRATION DEPRESSION; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP PATTERN; SLEEP STAGE; SOMNOLENCE; SUN EXPOSURE; TIME; UVULOPALATOPHARYNGOPLASTY;

EID: 0035088655     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(00)00083-6     Document Type: Review

References (149)

1. Sleep in normal aging and dementia
2. Sleep problems in older adults: Putting myths to bed
3. Sleep and aging
4. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in health men
5. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep
6. Sleep complaints among elderly persons: An epidemiologic study of three communities
7. Sleep in old age: Focus on gender differences
8. Incidence and remission of insomnia among elderly adults: An epidemiologic study of 6,800 persons over 3 years
9. Sleep complaints and depression in an aging cohort: A prospective perspective
10. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
11. Psychological problems associated with sleep deprivation in interns
12. Fatigue in doctors
13. After affect of sleep deprivation
14. The effect of sleep fragmentation on daytime function
15. Effect of sleep deprivation on driving safety in housestaff
16. Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II
17. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects
18. The effect of short-term sleep loss on respiration
19. Sleep quality and pulmonary function in the healthy elderly
20. The effect of sleep loss on breathing in patients with COPD
21. Evaluation and management of insomnia: An overview
22. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. 1
23. Failure of physician documentation of sleep complaints in hospitalized patients
24. Review and analysis of caregiver burden and nursing home placement
25. Sleep Hygiene
26. Moderate intensity exercise and self-rated quality of sleep in older adults
27. Physical fitness: Benefits of exercise for the older patient
28. Daily social and physical activity increases slow-wave sleep and daytime neuropsychological performance in the elderly
29. Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine
30. Effects of a daytime nap in the aged
31. Sleep in healthy elderly subjects: A 24-hour ambulatory polysomnographic study
32. Associations between retrospectively recalled napping behavior and later development of Alzheimers disease: Association with APOE genotypes
33. The siesta in the elderly: Risk factor of mortality
34. Is taking a siesta really a health hazard
35. Afternoon nap is good for the elderly
36. Identification and treatment of sleep problems in the elderly
37. Behavioral therapy for insomnia
38. Behavioral and pharmacologic therapies for late-life insomnia. A randomized controlled trial
39. Cognitive-behavioral therapy for late-life insomnia
40. Effects of moderately bright light on subjective evaluations on healthy elderly women
41. Effects of morning bright light on sleep in healthy elderly women
42. Light treatment for sleep disorders; Consensus Report. V. Age-related disturbances
43. Is melatonin a treatment for insomnia and jet lag?
44. Melatonin excretion is not related to sleep in the elderly
45. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons
46. Correlates of daytime sleepiness in 4578 elderly persons: The cardiovascular health study
47. Sleep disturbance, psychosocial correlated, and cardiovascular disease in 5201 older adults: The cardiovascular health study
48. Reliability and factor analysis of the Epworth Sleepiness Scale
49. Ten-year trends in the pharmacological treatment of insomnia
50. Management of monoamine oxidase inhibitor-associated insomnia with trazodone
51. Psychotropic medication and priapism: A comprehensive review
52. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia
53. Hypnotics: Efficacy and adverse effects
54. Adverse reactions to sedative/hypnotics: Three years experience
55. The use of sedative/hypnotic medication and its correlation with falling down in the hospital
56. Benzodiazepines and the risk of falls in nursing homes
57. Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes
58. Effects of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects
59. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea
60. Hypnotics: Basic mechanisms and pharmacology
61. Insomnia in the elderly: A review for the primary care practitioner
62. Effects of two hypnotic drugs on actual driving performance the next morning
63. Long-term treatment of insomnia with zolpidem: A multicenter general practitioner study of 107 patients
64. Perspectives on the management of insomnia in patients with chronic respiratory disorders
65. Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD
66. Safety and efficacy of zaleplon versus zolpidem in outpatients with chronic obstructive pulmonary disease (COPD) in insomnia
67. Safety and tolerance of zolpidem in the treatment of disturbed sleep: A post-marketing surveillance of 16944 cases
68. Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study
69. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study
70. Sleep-related breathing disorder is an independent risk factor for systemic hypertension
71. Prospective study of the association between sleep-disordered breathing and hypertension
72. Prevalence of sleep-disordered breathing in ages 40-64 years. A population-based survey
73. Sleep-disordered breathing in community dwelling elderly
74. The occurrence of sleep-disordered breathing among middle-aged adults
75. Hormone replacement therapy may alleviate sleep apnea in menopausal women: A pilot study
76. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women
77. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy
78. Effects of medroxyprogesterone acetate in obstructive sleep apnea
79. Medroxyprogesterone acetate in the treatment of obstructive sleep apnea
80. Obstructive sleep apnea due to endogenous testosterone production in a woman
81. Influence of testosterone on breathing during sleep
82. Assessment of the role of inheritance in sleep apnea syndrome
83. Epidemiology of sleep-disordered breathing
84. Sleep-disordered breathing in African-American elderly
85. Smoking as a risk factor for sleep-disordered breathing
86. What is hypopnea, anyway?
87. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research
88. Detection of flow limitation with a nasal cannula/pressure transducer system
89. Is sleep apnea syndrome in the elderly a specific entity?
90. Sleep-disordered breathing in the community-dwelling elderly
91. Epidemiology of sleep disorders
92. Natural history of sleep disordered breathing in community-dwelling elderly
93. Longitudinal changes in diary-and laboratory-based sleep measures in 'old old' and 'young old' subjects: A three-year follow-up
94. Longitudinal development of sleep-related respiratory disturbance in adult humans
95. Preliminary longitudinal assessment of sleep in the elderly
96. Comparison of sleep-disordered breathing among healthy elderly in the seventh, eighth and ninth decades of life
97. Sleep-related breathing and movement disorders in healthy elderly and demented subjects
98. Effect of age on sleep apnea in men
99. Gender differences in sleep disordered breathing in a community-based sample
100. Risk factors for sleep disordered breathing in heterogeneous geriatric populations
101. Sleep apnea: Prevalence of risk factors in a general population
102. Prevalence and correlates of sleep-disordered breathing in the Wisconsin Sleep Cohort Study
103. Central sleep apnea
104. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types, and their prevalences, consequences and presentations
105. Sleep-related respiratory disturbance and dementia in elderly females
106. Sleep-disordered breathing in normal and pathologic aging
107. Dementia in institutionalized elderly relation to sleep apnea
108. Are breathing disturbances in elderly equivalent to sleep apnea syndrome?
109. Effects of varying approaches for identifying respiratory disturbances on sleep apnea assessment
110. Hypopnea: A floating metric: Implications for prevalence, morbidity estimates, and case finding
111. Sleep apnea syndrome: A critical review of the apnea index as a diagnostic criterion
112. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly
113. Sleep-disordered breathing: Preliminary natural history and mortality results
114. Sleep apnea and mortality in an aged cohort
115. Predicting mortality in mixed depression and dementia using EEG sleep variables
116. Four-year follow-up of mortality and sleep-related respiratory disturbance in non-demented seniors
117. Sleep-disordered breathing in healthy aged persons: Fifth and final follow-up
118. Mortality and apnea index in obstructive sleep apnea; experience in 385 male patients
119. The health effects of obstructive sleep apnoea and the effectiveness of treatment with continuous positive airway pressure: A systematic review of the research evidence
120. Age-specific patterns of factors related to fatal motor vehicle traffic crashes: Focus on young and elderly drivers
121. Elderly drivers involved in road crashes: A profile
122. Sleep-disordered breathing in healthy aged persons: One-year follow-up of daytime sequelae
123. Neuropsychological function in mild sleep-disordered breathing
124. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome Arch
125. Sleep-disordered breathing and neuropsychological deficits
126. Sleep apnea in Alzheimer's dementia: Correlation with mental deterioration
127. Nocturnal polyuria in the elderly person
128. Sleep-disordered breathing in the healthy elderly. Clinically significant?
129. Sleep-disordered breathing in healthy aged persons: Two and three year follow-up
130. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea
131. What characterized patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment?
132. Oral appliances for the treatment of snoring and obstructive sleep apnea: A review
133. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome
134. Laser-assisted uvulopalatoplasty for snoring and obstructive sleep apnea: Results in 170 patients
135. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing
136. Radiofrequency volumetric reduction of the palate: And extended follow-up study
137. Radiofrequency volumetric tissue reduction of the soft palate: A new treatment for snoring
138. Midline radiofrequency tissue reduction of the palate for bothersome snoring and sleep-disordered breathing: A clinical trial
139. Sleep apnea and periodic movements in an aging sample
140. Periodic limb movements in sleep in community-dwelling elderly
141. Periodic limb movements and restless legs syndrome
142. Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic agent
143. Toward a better definition of restless legs syndrome
144. Restless legs syndrome and sleep bruxism; prevalence and association among Canadians
145. Prevalence and risk factors of RLS in an elderly population: The MEMO study memory and morbidity in Augsburg elderly
146. Epidemiology of restless legs symptoms in adults
147. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the American Academy of Sleep Medicine
148. Acute effect of nasal CPAP on periodic limb movements associated with breathing disorders during sleep